Brown Roots for Company, Funding
Sept. 27, 2013 | Providence Journal
Ocean State Angels, a seed-stage investment group, recently contributed an undisclosed amount to Tivorsan Pharmaceuticals, a biotech company formed on the basis of 25 years of research by Justin Fallon, a Brown University professor of medical science. Read more.
New Funding for Startup Using Cognitive & Brain Science
April 3, 2013 | Carnegie Mellon
Neon, a startup based on technology licensed from Brown, has secured more funding to continue developing a product that automatically selects the most visually appealing frame from a stream of online video to be used as the video's thumbnail. Neon's product is one of the first to use cognitive and brain sciences to increase audience engagement. Read more.
March 25, 2013 |
March 13, 2013 | Nabsys
Founded by scientists at Brown, Nabsys received funding this spring to support the commercial launch of a positional sequencing system for use in genome assembly and finishing and in analysis of structural variation in genomes. The new system will help genomic researchers to assemble short DNA sequences and to analyze structural variation in a high-throughput way. Read more.
PharmLogic and Brown Enter into License and Sponsored Research Agreements
Feb. 6, 2013 | PharmLogic
Brown chemistry professor Jason Sello has received funding from PharmLogic for his research and work in developing new antibacterial agents. Read more.
Microtissues and Sigma-Aldrich Sign Supply and Distribution Agreement for 3D Petri Dish
Dec. 6, 2012 | Microtissues Inc.
Brown licensee, Microtissues and Sigma-Aldrich signed a Supply and Distribution Agreement for the worldwide sales and marketing of the 3D Petri Dish. Read more.
Patent royalty income on the rise for U.
Sept 28, 2012 | Brown Daily Herald
The income the University earned as a result of patent royalties stemming from its research increased from 2011 to 2012. Read more.
Partnership Aims to Find New Treatment for Fragile X Syndrome and Autism
Aug 7, 2012 | Seaside Therapeutics
Seaside Therapeutics, a licensee of mGluR5 patents invented at Brown and Emory Universities, recently completed a licensing deal with Roche to advance new treatments for Fragile X Syndrome and autism spectrum disorders. Read more.
Building a better battery via technology crowdsourcing
March 15, 2012 | TVO
Brown is one of the first participants to join Allied MindStorm, an open innovation website that invites the public to brainstorm new commercial applications. Read more.
New Research Grant from Johnson & Johnson
March 6, 2012 | TVO
Brown received a grant from the Johnson & Johnson Corporate Office of Science & Technology (COSAT) for research projects with the potential to benefit patients and healthcare. Read more.